Effective treatments for sepsis remain elusive, despite numerous advances in treating infections and disease.
A new discovery published in the June 2013 issue of The FASEB Journal not only could help health care providers predict who is more and less likely to develop sepsis, but it also opens the doors to new therapies that actually address the root cause of the problem, rather than just managing the symptoms. This also has the potential to benefit patients suffering from influenza and other viral infections, as well as chronic inflammatory diseases such as periodontal disease, rheumatoid arthritis, inflammatory bowel disease and chronic obstructive pulmonary disease.
Infection and Sepsis-related Mortality Hotspots Identified Across US
Researchers have sought to determine the geographic distribution of many life-threatening conditions in the past, including stroke and cardiac arrest.
Advertisement
"Addressing infectious and inflammatory complications early and effectively in burn and trauma patients remains a significant unmet clinical need," said Daniel Irimia, M.D., Ph.D., a researcher involved in the work from the BioMEMS Resource Center and the Department of Surgery at Shriners Hospital for Children in Boston, MA. "This need is augmented by the difficulties of diagnosing infections early and the upsurge in frequency of multi-drug resistant bacteria."
To make this discovery, Irimia and colleagues studied two groups of rats with burn injuries and septic complications by designing a microfluidic assay to precisely measure the movement of isolated neutrophils. They found that the ability of neutrophils to move becomes progressively worse during the first week after the injury, and that a known compound, called resolvin D2, can restore neutrophil movement. Using neutrophil measurements as a guide, researchers optimized the parameters of the treatment, and as a result all treated animals survived, while all untreated animals died. This study suggests that measuring neutrophil motility could become a useful biomarker for the actual risk for septic complications in patients. Rather than relying on statistical data for each disease and patient group, measuring neutrophil movement could help personalize treatments for individual patients, resulting in better outcomes.
![Drug Does Not Significantly Reduce Risk of Death Among Patients With Severe Sepsis: Study]( "Drug Does Not Significantly Reduce Risk of Death Among Patients With Severe Sepsis: Study")
According to a study, administration of the drug eritoran to patients with severe sepsis and septic shock failed to demonstrate a significant effect.
"Reports of patients contracting deadly secondary infections while in the ICU continue to increase," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal, "but doctors have to find out what's wrong, and find it out quickly. This research should lead to faster diagnosis and better treatments for burns and sepsis. It's an important step on the way to new therapeutics."
Source: Eurekalert
Drug Does Not Significantly Reduce Risk of Death Among Patients With Severe Sepsis: Study
According to a study, administration of the drug eritoran to patients with severe sepsis and septic shock failed to demonstrate a significant effect.
Advertisement
"Reports of patients contracting deadly secondary infections while in the ICU continue to increase," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal, "but doctors have to find out what's wrong, and find it out quickly. This research should lead to faster diagnosis and better treatments for burns and sepsis. It's an important step on the way to new therapeutics."
Source: Eurekalert
Research may Lead to New Strategies Against Sepsis
In sepsis, scientists at the Center for Translational Medicine at the Temple University School of Medicine are inching closer to solving a long-standing mystery.
Advertisement
 Link Between Vascular Damage and Adhesion of Pathogenic Bacteria in Meningococcal Sepsis RevealedResearchers have shed more light on the formation of cutaneous lesions of meningococcal sepsis due to the adhesion of Neisseria meningitidis to human microvessels in a humanized mouse model. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
Consuming a diet rich in saturated fats triggers persistent, low-level inflammation within the body, ultimately contributing to the onset of metabolic syndrome.
Ae. aegypti mosquitoes are carriers of "arthropod-borne" or "arbo-" viruses, which encompass the dengue virus, yellow fever virus, Zika virus, and chikungunya virus.
